Article Versions Notes

Lim XR, Liu S, Howe HS, Leong KP, Elangovan E, Huang C-H, Kong KO, Thong BYH, Vasoo S, Leung BPL. The Role of Anti-Interferon-α Autoantibodies in Severe COVID-19: Implications for Vaccination Prioritization. Vaccines. 2025; 13(7):742. https://doi.org/10.3390/vaccines13070742

Lim, Xin Rong, Shiyu Liu, Hwee Siew Howe, Khai Pang Leong, Elampirai Elangovan, Chiung-Hui Huang, Kok Ooi Kong, Bernard Yu Hor Thong, Shawn Vasoo, and Bernard Pui Lam Leung. 2025. "The Role of Anti-Interferon-α Autoantibodies in Severe COVID-19: Implications for Vaccination Prioritization" Vaccines 13, no. 7: 742. https://doi.org/10.3390/vaccines13070742

Lim, X. R., Liu, S., Howe, H. S., Leong, K. P., Elangovan, E., Huang, C.-H., Kong, K. O., Thong, B. Y. H., Vasoo, S., & Leung, B. P. L. (2025). The Role of Anti-Interferon-α Autoantibodies in Severe COVID-19: Implications for Vaccination Prioritization. Vaccines, 13(7), 742. https://doi.org/10.3390/vaccines13070742